featured
Efficacy and Safety of Deucravacitinib in Patients With Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials
Br J Dermatol 2024 Jan 16;[EPub Ahead of Print], M Lebwohl, RB Warren, H Sofen, S Imafuku, C Paul, JC Szepietowski, L Spelman, T Passeron, E Vritzali, A Napoli, RM Kisa, A Buck, S Banerjee, D Thaçi, A BlauveltFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.